REPORT ID 448

EMEA (Europe, Middle East and Africa) Serum (Blood) Market Report 2017

Publish Date
01-Dec-17
Pages
114
Format
Electronic (PDF)

In this report, the EMEA Serum (Blood) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Serum (Blood) for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Serum (Blood) market competition by top manufacturers/players, with Serum (Blood) sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Thermo Fisher (Life-Tech)
    Sigma-Aldrich
    Merck
    Corning
    Bovogen
    Moregate Biotech
    Biowest
    Gemini
    Bioind
    Tissue Culture Biologicals
    Animal Technologies
    South Pacific Sera
    Lanzhou Minhai
    Changchun Xinuo
    Wuhan Sanli

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Bovine Serum
    FBS

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Biological Products
    Research

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Serum (Blood) Market Report 2017
1 Serum (Blood) Overview
    1.1 Product Overview and Scope of Serum (Blood)
    1.2 Classification of Serum (Blood)
        1.2.1 EMEA Serum (Blood) Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Serum (Blood) Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Bovine Serum
        1.2.4 FBS
    1.3 EMEA Serum (Blood) Market by Application/End Users
        1.3.1 EMEA Serum (Blood) Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Biological Products
        1.3.3 Research
    1.4 EMEA Serum (Blood) Market by Region
        1.4.1 EMEA Serum (Blood) Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Serum (Blood) (2012-2022)
        1.5.1 EMEA Serum (Blood) Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Serum (Blood) Revenue and Growth Rate (2012-2022)

2 EMEA Serum (Blood) Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Serum (Blood) Market Competition by Players/Manufacturers
        2.1.1 EMEA Serum (Blood) Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Serum (Blood) Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Serum (Blood) Sale Price by Players (2012-2017)
    2.2 EMEA Serum (Blood) (Volume and Value) by Type/Product Category
        2.2.1 EMEA Serum (Blood) Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Serum (Blood) Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Serum (Blood) Sale Price by Type (2012-2017)
    2.3 EMEA Serum (Blood) (Volume) by Application
    2.4 EMEA Serum (Blood) (Volume and Value) by Region
        2.4.1 EMEA Serum (Blood) Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Serum (Blood) Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Serum (Blood) Sales Price by Region (2012-2017)

3 Europe Serum (Blood) (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Serum (Blood) Sales and Value (2012-2017)
        3.1.1 Europe Serum (Blood) Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Serum (Blood) Revenue and Growth Rate (2012-2017)
    3.2 Europe Serum (Blood) Sales and Market Share by Type
    3.3 Europe Serum (Blood) Sales and Market Share by Application
    3.4 Europe Serum (Blood) Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Serum (Blood) Sales Volume by Countries (2012-2017)
        3.4.2 Europe Serum (Blood) Revenue by Countries (2012-2017)
        3.4.3 Germany Serum (Blood) Sales and Growth Rate (2012-2017)
        3.4.4 France Serum (Blood) Sales and Growth Rate (2012-2017)
        3.4.5 UK Serum (Blood) Sales and Growth Rate (2012-2017)
        3.4.6 Russia Serum (Blood) Sales and Growth Rate (2012-2017)
        3.4.7 Italy Serum (Blood) Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Serum (Blood) Sales and Growth Rate (2012-2017)

4 Middle East Serum (Blood) (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Serum (Blood) Sales and Value (2012-2017)
        4.1.1 Middle East Serum (Blood) Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Serum (Blood) Revenue and Growth Rate (2012-2017)
    4.2 Middle East Serum (Blood) Sales and Market Share by Type
    4.3 Middle East Serum (Blood) Sales and Market Share by Application
    4.4 Middle East Serum (Blood) Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Serum (Blood) Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Serum (Blood) Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Serum (Blood) Sales and Growth Rate (2012-2017)
        4.4.4 Israel Serum (Blood) Sales and Growth Rate (2012-2017)
        4.4.5 UAE Serum (Blood) Sales and Growth Rate (2012-2017)
        4.4.6 Iran Serum (Blood) Sales and Growth Rate (2012-2017)

5 Africa Serum (Blood) (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Serum (Blood) Sales and Value (2012-2017)
        5.1.1 Africa Serum (Blood) Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Serum (Blood) Revenue and Growth Rate (2012-2017)
    5.2 Africa Serum (Blood) Sales and Market Share by Type
    5.3 Africa Serum (Blood) Sales and Market Share by Application
    5.4 Africa Serum (Blood) Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Serum (Blood) Sales Volume by Countries (2012-2017)
        5.4.2 Africa Serum (Blood) Revenue by Countries (2012-2017)
        5.4.3 South Africa Serum (Blood) Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Serum (Blood) Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Serum (Blood) Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Serum (Blood) Sales and Growth Rate (2012-2017)

6 EMEA Serum (Blood) Manufacturers/Players Profiles and Sales Data
    6.1 Thermo Fisher (Life-Tech)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Serum (Blood) Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Thermo Fisher (Life-Tech) Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sigma-Aldrich
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Serum (Blood) Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sigma-Aldrich Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merck
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Serum (Blood) Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Corning
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Serum (Blood) Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Corning Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Bovogen
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Serum (Blood) Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bovogen Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Moregate Biotech
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Serum (Blood) Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Moregate Biotech Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Biowest
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Serum (Blood) Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Biowest Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Gemini
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Serum (Blood) Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Gemini Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Bioind
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Serum (Blood) Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Bioind Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Tissue Culture Biologicals
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Serum (Blood) Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Tissue Culture Biologicals Serum (Blood) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Animal Technologies
    6.12 South Pacific Sera
    6.13 Lanzhou Minhai
    6.14 Changchun Xinuo
    6.15 Wuhan Sanli

7 Serum (Blood) Manufacturing Cost Analysis
    7.1 Serum (Blood) Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Serum (Blood)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Serum (Blood) Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Serum (Blood) Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Serum (Blood) Market Forecast (2017-2022)
    11.1 EMEA Serum (Blood) Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Serum (Blood) Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Serum (Blood) Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Serum (Blood) Price and Trend Forecast (2017-2022)
    11.2 EMEA Serum (Blood) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Serum (Blood) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Serum (Blood) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Serum (Blood) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Serum (Blood) Sales Forecast by Type (2017-2022)
    11.7 EMEA Serum (Blood) Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer